Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study.
about
Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Efficacy and safety of ruxolit ...... results from a phase 2a study.
@en
Efficacy and safety of ruxolit ...... results from a phase 2a study.
@nl
type
label
Efficacy and safety of ruxolit ...... results from a phase 2a study.
@en
Efficacy and safety of ruxolit ...... results from a phase 2a study.
@nl
prefLabel
Efficacy and safety of ruxolit ...... results from a phase 2a study.
@en
Efficacy and safety of ruxolit ...... results from a phase 2a study.
@nl
P2093
P2860
P1433
P1476
Efficacy and safety of ruxolit ...... results from a phase 2a study.
@en
P2093
Antonis Kattamis
Aurelio Maggio
Brian Gadbaw
Bruyère Mahuzier
Elena Cassinerio
Noppadol Siritanaratkul
Norbert Hollaender
Yesim Aydinok
Zeynep Karakas
P2860
P304
P356
10.1182/BLOOD-2017-06-790121
P407
P577
2017-11-02T00:00:00Z